ENTEST BIOMEDICAL INCORPORATED (OTCMKTS:ENTB) had a decrease of 83.06% in short interest. ENTB’s SI was 5,100 shares in March as released by FINRA. Its down 83.06% from 30,100 shares previously. With 77,000 avg volume, 0 days are for ENTEST BIOMEDICAL INCORPORATED (OTCMKTS:ENTB)’s short sellers to cover ENTB’s short positions. About 50,535 shares traded. Entest Biomedical Inc (OTCMKTS:ENTB) has risen 923.40% since August 17, 2016 and is uptrending. It has outperformed by 914.08% the S&P500.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.